Sabby Management, LLC Insmed Inc Transaction History

Sabby Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$11.6 - $18.7 $174,000 - $280,500	-15,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$18.95 - $28.08 $53,060 - $78,624	-2,800 Reduced 15.73%	15,000 $303,000
Q2 2018 Aug 14, 2018	BUY	$20.0 - $29.72 $90,000 - $133,740	4,500 Added 33.83%	17,800 $421,000
Q1 2018 May 15, 2018	BUY	$21.69 - $32.99 $288,477 - $438,767	13,300 New	13,300 $300,000

498

189M

3.21M

2.72M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.8B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.